Covid-19: Scientists in ongoing-process of developing process

Covid-19: Scientists in ongoing-process of developing process

- A team of medical researchers is developing a vaccine for coronavirus from a strain virus, Sars-Cov-2, that causes it

- With the process of combining antigens from the causative virus with a "backbone" protein from a flu virus, the scientists hope to come up with a cure within weeks

- According to them, when the vaccine is ready, it will be passed into a patient's body through the lungs, mimicking the way Covid-19 gets into the system

A dedicated team of local researchers is working on a Covid-19 vaccine with a modification process that can be completed within three weeks to combat Sars-Cov-2 virus and go through a human trial in six months.

It should be noted that Sars-Cov-2 is a kind of virus strain that causes the deadly coronavirus and it is a respiratory illness.

The team involved in the vaccine development is called Home-grown Esco Aster and they are working with the United States biotechnology company, Vivaldi Biosciences, as they combine proteins from different viruses to find a cure, StraitsTimes reports.

COVID-19 may never go away, just like HIV - WHO declares
Nandini Prabhakar beside the machine being used in the ongoing process of developing the vaccine. Photo source: StraitsTimes

Nandini Prabhakar beside the machine being used in the ongoing process of developing the vaccine. Photo source: StraitsTimes
Source: UGC

The vaccine they are working on is tagged Esco-Aster DeltaCov and was made by putting together antigens from Sars-Cov-2 virus with “backbone” protein from a flu virus.

"Viruses actually want to lie low and not be recognised - they want to evade the immune system and not cause any response.

"By having this backbone... we can awaken the immune system to realise there's a novel virus and create the antibodies needed to kill it," Esco Aster’s chief executive, Lin Xiangliang, said.

Dr Nandini Prabhakar, a senior scientist, has said that the use of the “backbone” will speed up the process of finding a vaccine.

Another thing worthy of note is that when the vaccine is ready, it can be administered into a patient’s body through a nasal spray, the same way the virus gets into the human body.

Meanwhile, earlier reported that the Sierra Leonean government appointed a Nigerian, Dr Laoluwa Adejayan, as the head of its Covid-19 Task Force.

These were the things I took to recover from Covid-19 - Coronavirus survivor in Kano reveals

In explaining how the Nigerian is better suited for the position, the government said that they took the action on the basis that Laoluwa’s work in recent years as a foreign medical practitioner has spoken for itself.

PAY ATTENTION: Download our mobile app to enjoy the latest news

After the appointment, the government increased his salary to $20,000 (N7,740,200) monthly, a 100% increment over his previous salary.

It should be noted that Adejayan graduated from Ladoke Akintola University of Technology, Ogbomoso and reportedly did his National Youth Service Corps programme in Bayelsa state.

Also, the president of Sierra Leone, Julius Maada Bio, sent a letter to President Muhammadu Buhari informing him about the appointment as he described the Nigerian as a good ambassador. ( - We have upgraded to serve you better

Coronavirus: Does the Madagascar cure really work? | Legit TV

Covid-19: Israel launches own disinfectant that kills 100% coronavirus

Source: Legit Newspaper

Mailfire view pixel